ResistanceBio
Latest round
- Seed
Last raised
- Jul 2022
Total raised
- Undisclosed
Investors
- 6
About ResistanceBio
Based in California, US, and founded by Nick Goldner (CEO), and Chris Bulow (COO), ResistenceBio, a portfolio company of Alumni Ventures, is a biotechnology company that identifies and creates novel therapeutics for cancer patients who are resistant to clinical treatment. The firm employs its proprietary drug and target discovery platform, ResCu, that predicts the resistance of cancerous cells during clinical treatments to identify resistance target networks and resistance biomarkers that aid pharma companies in developing cancer treatments. The platform helps to determine the best drug for a cancer type, and the best patient population for treatment and identifies novel resistance targets for new therapies.
Who invested in ResistanceBio
6 investors across 1 round
See all investors in ResistanceBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jul 20, 2022
Amount
Undisclosed
Investors
Questions about ResistanceBio
Who invested in ResistanceBio?
ResistanceBio has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ResistanceBio raised?
ResistanceBio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ResistanceBio last raise money?
ResistanceBio's most recent round on record is a Seed, in Jul 2022.
What does ResistanceBio do?
Based in California, US, and founded by Nick Goldner (CEO), and Chris Bulow (COO), ResistenceBio, a portfolio company of Alumni Ventures, is a biotechnology company that identifies and creates novel therapeutics for cancer patients who are resistant to clinical treatment.
Where is ResistanceBio headquartered?
ResistanceBio is headquartered in San Carlos, US.
Which VCs invest in companies like ResistanceBio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ResistanceBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like ResistanceBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.